- Change Language
- Home
- Overview
- Subscribers
- Locations
- Newsroom
The European Medicines Agency (EMA) has granted conditional marketing authorization for the Janssen COVID-19 vaccine. The EMA announced this today, with a spokesperson commenting: “With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens…This is the first vaccine which can be used as a single dose.” According to the article, data from the clinical trials has shown a 67% efficacy rate. Further monitoring of the vaccine’s safety and efficacy will continue.
Countering Misinformation & Disinformation: Practical Training for Organizations
Practical skills to detect, verify, and respond across an evolving information landscape
Additional data provided by
English
Japanese
